Quantcast

Latest Immunoglobulin E Stories

2014-07-13 12:20:51

CINCINNATI, July 13, 2014 /PRNewswire-USNewswire/ -- New research in Nature Genetics identifies a novel genetic and molecular pathway in the esophagus that causes eosinophillic esophagitis (EoE), opening up potential new therapeutic strategies for an enigmatic and hard-to-treat food allergy. http://photos.prnewswire.com/prnvar/20110406/MM79025LOGO EoE is a chronic inflammatory disorder of the esophagus. The condition is triggered by allergic hypersensitivity to certain foods and...

2014-06-06 23:09:30

Dr. Anne Marie Salapatek, President & Chief Scientific Officer of Inflamax Research, will be presenting results of a meta-analysis outlining statistically significant correlations between house dust mite symptoms in the traditional Field trial approach and those collected from patients in the Environmental Exposure Chamber (EEC). These findings support the use of EEC allergen challenge approach for pivotal testing. Mississauga, ON (PRWEB) June 06, 2014 Dr. Salapatek, an...

2014-05-28 08:31:16

MONROVIA, Calif., May 28, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced that the first subject has been dosed in a Phase 1a clinical trial of XmAb®7195. XmAb7195 is a monoclonal antibody engineered to suppress IgE via three distinct mechanisms of action as a potential treatment for asthma and...

2014-05-15 08:32:10

Rapid IgE clearance by XmAb7195 shows potential as a disease modifying treatment for allergy and asthma MONROVIA, Calif., May 15, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced it will present preclinical data comparing activity of XmAb®7195 to omalizumab in reducing IgE, a protein responsible...

2014-05-02 23:08:56

Young Researcher Invited to Present Findings at the American Gastroenterological Association’s (AGA) Digestive Disease Week in Chicago; Teen Investigating How Fucose Affects the Permeability of Gut Mucosa Cells Against Bacteria Hunting Valley, OH (PRWEB) May 02, 2014 University School junior William Xin has learned a lot about the value of patience when it comes to working in a medical research lab. “Lab work requires quite a bit of repetitive work to get enough data for...

2014-03-19 16:23:41

Conference call to be held today at 4:30 p.m. EDT MONROVIA, Calif., March 19, 2014 /PRNewswire/ -- Xencor Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today reported financial results for the fourth quarter and full year ended December 31, 2013 and provided a review of business highlights. "We are very pleased that Xencor now has five clinical...

2014-03-01 12:20:30

For U.S. Media Only RIDGEFIELD, Conn., March 1, 2014 /PRNewswire/ -- Boehringer Ingelheim today presented data from Phase 3 studies of tiotropium delivered via the Respimat(®) inhaler in mild, moderate and severe asthma patients at the 2014 American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting in San Diego. Tiotropium is being studied to determine its efficacy and safety in treating asthma patients and is not currently approved for this indication. The first results...

Bee Sting Allergies Could Be Defense Mechanism
2013-10-25 05:04:12

[ Watch the Video: The Evolution Of An Allergy ] redOrbit Staff & Wire Reports - Your Universe Online While bee stings could be fatal to those who are allergic to the insect’s venom, that type of adverse biological reaction is actually the body’s attempt to protect a person from potentially deadly toxins. Writing in Wednesday’s edition of the journal Immunity, scientists from the Stanford University School of Medicine and their colleagues describe how they injected mice...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related